• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    The Acrotec Group Acquires Friedrich Daniels

    Siemens Healthineers Presents Mammomat B.brilliant

    MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire

    ISO 13485 Certification Awarded to Inspira Technologies

    ZOLL Expands Temperature Management Portfolio to Include IQool System
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    The Arthur G Russell Company

    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    The Arthur G Russell Company

    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Johari Digital Healthcare Ltd.

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Nēsos Earbud Receives Validation for Treatment of Rheumatoid Arthritis

    New study shows promising efficacy and safety profile for novel ‘e-mmunotherapy’ approach to disease treatment.

    Nēsos Earbud Receives Validation for Treatment of Rheumatoid Arthritis
    The study demonstrated a meaningful reduction in the signs of symptoms of RA in 53% of the treated patients after three months. Image courtesy of Nēsos.
    Charles Sternberg, Assistant Editor02.02.21
    Nēsos has published data from a pilot clinical study demonstrating the power of its e-mmunotherapy platform in the treatment of rheumatoid arthritis.
     
    The data, published in The Lancet Rheumatology, focuses on a clinical study evaluating the Nēsos developed e-mmunotherapy treatment in a cohort of rheumatoid arthritis patients. Patients with moderately to severely active rheumatoid arthritis (RA) despite treatment with conventional synthetic disease-modifying antirheumatic drugs (csDMARD) received daily e-mmunotherapy.
     
    Nesos’ novel e-mmunotherapy approach uses electrical pulse sequences delivered via purpose-designed earbuds to target the cholinergic anti-inflammatory pathway. By enabling the brain to regulate immune function through this neural input, e-mmunotherapy has the potential to stand as a new treatment option without the side-effect profile of existing therapies. 
     
    Results of the Study
    The study demonstrated a meaningful reduction in the signs of symptoms of RA in 53% of the treated patients after three months based on the American College of Rheumatology (ACR) response criteria (ACR20). In addition, 37% of patients achieved low disease activity, while 23% achieved remission. Significant improvement in patient-reported outcomes suggests that the device might help address key unmet needs for patients with rheumatoid arthritis, such as those concerning pain and sleep. Almost two-thirds of patients saw improvements in their ability to fall asleep at night, and 70% of patients had a reduction in the number of times pain woke them up at night.
     
    “If this data is validated in further clinical testing, e-mmunotherapy can provide a viable new therapeutic option for rheumatoid arthritis patients,” said professor Sara Marsal MD, University Hospital Vall d’Hebron, Barcelona, Spain, and principal investigator in this first human multicenter study. “The potential for meaningful clinical benefit plus an improved side effect profile, compared to biologic therapies like TNF-alpha inhibitors or synthetic DMARDs like JAK inhibitors, will drive future development efforts.” 
     
    85% of patients reported they were either satisfied or very satisfied with using the device and 93% of patients reported that they saw some level of improvement in activity, symptoms, emotions, and overall quality of life. There was one device-related adverse event, a superficial skin abrasion at the site where the earpiece contacted the ear, that resolved without intervention.
     
    “We are very excited by the data thus far and think this approach could provide real benefit for patients in the future,” added Dr. Matthew Baker MD clinical chief, Division of Immunology and Rheumatology, Stanford University, and an advisor to Nēsos. “The overwhelmingly positive feedback we have received from patients has been great to see. We look forward to taking the next steps in further understanding the potential this device has to offer. 
     
    Based on the results of this pilot study, Nēsos has initiated a double-blinded, randomized, sham-controlled trial to be conducted at multiple study sites in the United States. 
    Related Searches
    • Neurological
    Related Knowledge Center
    • Neurological
    Suggested For You
    Nissha Medical Technologies Nissha Medical Technologies
    Simbex Simbex
    IMA Automation North America IMA Automation North America
    WESTPAK Inc. WESTPAK Inc.
    Breakthrough Device Designation Granted for New Neuromodulation Platform Breakthrough Device Designation Granted for New Neuromodulation Platform
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Babson Diagnostics Raises $31 Million in Series B Funding Babson Diagnostics Raises $31 Million in Series B Funding
    Paragonix Launches Global Registry for Studying Donor Lung Preservation Paragonix Launches Global Registry for Studying Donor Lung Preservation
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Improved Outcomes Proven With Insulet’s Omnipod 5 System Improved Outcomes Proven With Insulet’s Omnipod 5 System
    Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe Masimo Launches Single-Patient-Use rainbow SuperSensor in Europe
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    Quanta Raises $245 Million in Series D Funding Round Quanta Raises $245 Million in Series D Funding Round
    Know Labs Awarded New Patent for Non-Invasive Diagnostic Tech Platform Know Labs Awarded New Patent for Non-Invasive Diagnostic Tech Platform
    Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices Mayo Clinic, Google Research AI Software Could Boost Brain Stim Devices

    Related Buyers Guide Companies

    • Nissha Medical Technologies

      ...
      Amy Jeary, Market Development Manager 11.18.22

    • Simbex

      ...
      Greg Lange, Chief Business Development Officer 10.05.22

    • IMA Automation North America

      ...
      Paul Beduze, Sales Manager 09.23.22


    • Packaging & Sterilization
      WESTPAK Inc.

      WESTPAK Inc.

      ...
      Tim Eells, WESTPAK, Inc. 03.04.22

    • Breakthrough Device Designation Granted for New Neuromodulation Platform

      Breakthrough Device Designation Granted for New Neuromodulation Platform

      In a pilot study treating refractory epilepsy with Neuroelectrics’ Starstim platform, patients experienced a 44 percent median reduction in seizure frequency.
      Business Wire 09.22.21

    Loading, Please Wait..

    Trending
    • ZOLL Expands Temperature Management Portfolio To Include IQool System
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • ProPublica Investigation Claims Philips Kept CPAP Issues From The FDA For 11 Years
    Breaking News
    • The Acrotec Group Acquires Friedrich Daniels
    • Siemens Healthineers Presents Mammomat B.brilliant
    • MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire
    • ISO 13485 Certification Awarded to Inspira Technologies
    • ZOLL Expands Temperature Management Portfolio to Include IQool System
    View Breaking News >
    CURRENT ISSUE

    October 2023

    • MPO's 2023 Medtech Supply Chain Survey
    • Exceeding Medical Device Extrusion Expectations
    • Medical Device Micromolders Discuss the 'Minor Details'
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    PPG and Dutch University to Develop World's First Off-Road Solar Car
    Selektope Keeps Global Mercy’s Hull Barnacle-Free
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    The Acrotec Group Acquires Friedrich Daniels
    Siemens Healthineers Presents Mammomat B.brilliant
    MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Peptone Expands Leadership Team with Key Executive Hires
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Estée Lauder Executive Pay Packages Fall in Fiscal 2023
    Happi

    Latest Breaking News From Happi

    Stanford Researchers Study Skin and Sensorial Perception
    L’Oréal Awarded US Patent for Makeup
    GK Hair Launches Juvexin Cream Color Line
    Ink World

    Latest Breaking News From Ink World

    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Arkema Accelerates Its Organic Growth
    Toyo Printing Inks Participating in Eurasia Packaging Istanbul Fair
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Spinnaker's Troy manufacturing site earns ISO 9001:2015 certification
    APR publishes expanded Global Design Catalog
    Anjou adds Bobst Digital Master 340
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Ed Thomas Receives INDA Lifetime Technical Service Award
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Medacta Completes First U.S. MyPAO Hip Surgery
    FDA OKs Acuitive's Resorbable CITRELOCK DUO to Repair Bicep Tears
    FDA Clears 4WEB Medical's New Integrated Cervical Plate
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio
    Emerson Ventures Invests in First Resonance

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login